Otsuka Holdings
Otsuka Holdings Co., Ltd. is a major global healthcare and nutraceutical group headquartered in Tokyo, Japan, operating a diverse network of specialized subsidiaries. The company operates primarily across two complementary business segments: prescription pharmaceuticals focused on central nervous system disorders and oncology, and functional nutraceutical consumer products. Its diverse product portfolio encompasses prescription medicines, medical diagnostic devices, functional rehydration beverages, clinical nutrition, and consumer skincare formulations. Widely recognized for creating innovative psychiatric medications and popular wellness beverages like Pocari Sweat, Otsuka effectively bridges medical science with everyday consumer health. To address the growing health demands of an aging global population, the firm actively develops targeted therapies for Alzheimer's disease, cognitive decline, and chronic age-related metabolic disorders. The corporation invests heavily in clinical research programs, biotechnology partnerships, and research facilities across Asia, North America, and Europe. Dedicated to holistic wellbeing, Otsuka Holdings remains committed to delivering creative healthcare solutions that promote long-term human vitality.
69 of the funds FundTelligence covers report a position in Otsuka Holdings.
- Legal name
- Otsuka Holdings Co LTD
- Sector
- Health Care
- Country
- Japan
- Funds holding it
- 69
- Exposure themes
- Mental Health, Psychiatry, Schizophrenia & Psychosis
Funds holding Otsuka Holdings
- DWS Invest CROCI Japan — DWS · 3.42 % (full portfolio disclosed, June 2026)
- Handelsbanken Japan Tema — Handelsbanken · 2.0 % (full portfolio disclosed, October 2026)
- Danske Invest Japan — Danske Invest · 1.95 % (full portfolio disclosed, August 2026)
- Danske Invest Japan Index Restricted — Danske Invest · 1.28 % (full portfolio disclosed, July 2026)
- Schroder ISF Japanese Opportunities — Schroders · 1.24 % (full portfolio disclosed, June 2026)
- Nordea Japanese Sustainable Enhanced — Nordea Funds · 1.23 % (full portfolio disclosed, September 2026)
- Storebrand Japan — Storebrand · 1.18 % (full portfolio disclosed, October 2026)
- DWS Invest CROCI World Value — DWS · 1.03 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 69 funds holding it.